erlotinib has been researched along with nocodazole in 2 studies
Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (nocodazole) | Trials (nocodazole) | Recent Studies (post-2010) (nocodazole) |
---|---|---|---|---|---|
221 | 0 | 180 | 3,078 | 0 | 655 |
Protein | Taxonomy | erlotinib (IC50) | nocodazole (IC50) |
---|---|---|---|
Chain A, Glutathione-requiring prostaglandin D synthase | Homo sapiens (human) | 65 | |
nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 0.8334 | |
Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.64 | |
Tubulin alpha-1A chain | Sus scrofa (pig) | 1.3775 | |
Tubulin beta chain | Sus scrofa (pig) | 0.76 | |
Tubulin beta-4A chain | Homo sapiens (human) | 1.2975 | |
Tubulin beta chain | Homo sapiens (human) | 1.2975 | |
Tubulin alpha-3C chain | Homo sapiens (human) | 1.2975 | |
Adenosine receptor A2a | Homo sapiens (human) | 7.509 | |
Tubulin alpha-1B chain | Homo sapiens (human) | 1.2975 | |
Tubulin alpha-4A chain | Homo sapiens (human) | 1.2975 | |
Tubulin beta-4B chain | Homo sapiens (human) | 1.2975 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.232 | |
Tubulin beta-3 chain | Homo sapiens (human) | 1.2975 | |
Tubulin beta-2A chain | Homo sapiens (human) | 1.2975 | |
Tubulin beta-8 chain | Homo sapiens (human) | 1.2975 | |
Tubulin beta-2B chain | Bos taurus (cattle) | 2.3 | |
Tubulin alpha-3E chain | Homo sapiens (human) | 1.2975 | |
Tubulin alpha-1A chain | Homo sapiens (human) | 1.2975 | |
Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 2.3 | |
Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 2.3 | |
Tubulin alpha-1C chain | Homo sapiens (human) | 1.2975 | |
Tubulin beta-6 chain | Homo sapiens (human) | 1.2975 | |
Tubulin beta-2B chain | Homo sapiens (human) | 1.2975 | |
Tubulin beta-1 chain | Homo sapiens (human) | 1.2975 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernardino, AMR; Boechat, N; Dos Santos, MS; Faria, JV; Miguita, AGC; Vegi, PF | 1 |
Liu, Y; Xu, Z; Zhao, SJ | 1 |
2 review(s) available for erlotinib and nocodazole
Article | Year |
---|---|
Recently reported biological activities of pyrazole compounds.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Humans; Pyrazoles | 2017 |
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |